(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 8. BDNF maintains the number and density of presynaptic specializations in RGC
axon terminals affected by NMDA receptor blockade. (A) APV significantly
decreased GFP-synaptobrevin cluster number versus control 2 hours after
treatment. Co-injection of APV and BDNF rescued GFP-synaptobrevin labeled
presynaptic sites, significantly reducing the effects of APV on
GFP-synaptobrevin cluster number for a period of 8 hours. (B) Total branch
number was not affected by APV+ BDNF. (C) GFP-synaptobrevin cluster density
was significantly decreased in the APV-treated tadpoles. BDNF maintained
GFP-synaptobrevin cluster density in RGC axons co-treated with APV. The
asterisks indicate significance between APV alone and APV+BDNF. (A,C) APV+BDNF
is significantly different from control at the 0-4, 0-6, 0-8, 0-24 time
intervals; *P
0.05; **P
0.005;
***P
0.0005. n=14 axon arbors in control,
n=10 in APV, n=12 in MK801 and n=11 in
APV+BDNF.